Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

709 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman's age and markers of ovarian reserve.
Di Paola R, Garzon S, Giuliani S, Laganà AS, Noventa M, Parissone F, Zorzi C, Raffaelli R, Ghezzi F, Franchi M, Zaffagnini S. Di Paola R, et al. Arch Gynecol Obstet. 2018 Nov;298(5):1029-1035. doi: 10.1007/s00404-018-4906-2. Epub 2018 Sep 21. Arch Gynecol Obstet. 2018. PMID: 30242498
Female adolescents and young women previously treated for pediatric malignancies: assessment of ovarian reserve and gonadotoxicity risk stratification for early identification of patients at increased infertility risk.
Parissone F, Di Paola R, Balter R, Garzon S, Zaffagnini S, Neri M, Vitale V, Tridello G, Cesaro S. Parissone F, et al. Among authors: di paola r. J Pediatr Endocrinol Metab. 2020 Oct 19;34(1):25-33. doi: 10.1515/jpem-2020-0272. Print 2021 Jan 27. J Pediatr Endocrinol Metab. 2020. PMID: 33068384
A novel de novo partial xq duplication in a girl with short stature, nonverbal learning disability and diminished ovarian reserve - effect of growth hormone treatment and fertility preservation strategies: a case report and up-to-date review.
Parissone F, Pucci M, Meneghelli E, Zuffardi O, Di Paola R, Zaffagnini S, Franchi M, Santangelo E, Cantalupo G, Cavarzere P, Antoniazzi F, Piacentini G, Gaudino R. Parissone F, et al. Among authors: di paola r. Int J Pediatr Endocrinol. 2020;2020:1. doi: 10.1186/s13633-019-0071-z. Epub 2020 Jan 9. Int J Pediatr Endocrinol. 2020. PMID: 31938033 Free PMC article.
Correction: Hydrogen sulfide-releasing cyclooxygenase inhibitor ATB-346 enhances motor function and reduces cortical lesion volume following traumatic brain injury in mice.
Campolo M, Esposito E, Ahmad A, Di Paola R, Paterniti I, Cordaro M, Bruschetta G, Wallace JL, Cuzzocrea S. Campolo M, et al. Among authors: di paola r. J Neuroinflammation. 2024 May 28;21(1):139. doi: 10.1186/s12974-024-03131-6. J Neuroinflammation. 2024. PMID: 38807141 Free PMC article. No abstract available.
Correction: D'Amico et al. Toxic Exposure to Endocrine Disruptors Worsens Parkinson's Disease Progression through NRF2/HO-1 Alteration. Biomedicines 2022, 10, 1073.
D'Amico R, Gugliandolo E, Siracusa R, Cordaro M, Genovese T, Peritore AF, Crupi R, Interdonato L, Di Paola D, Cuzzocrea S, Fusco R, Impellizzeri D, Di Paola R. D'Amico R, et al. Among authors: di paola r. Biomedicines. 2024 Apr 10;12(4):834. doi: 10.3390/biomedicines12040834. Biomedicines. 2024. PMID: 38672284 Free PMC article.
709 results